|
Advanced PMPRB
Our next "Advanced PMPRB" seminar will be held in Fall 2010.
Outline
This in-depth, day-long session provides a greater understanding of the PMPRB, especially in the areas of
Voluntary Compliance Undertakings, Hearings, Category 2 Drugs, and Category 3 Drugs.
The seminar includes analyses of past cases and precedents, highlighting the challenges and opportunities associated with regulatory pricing in Canada, as well as workshops
Topics covered include:
- The enforcement process, in particular a close examination of the voluntary compliance undertaking process and hearing rules.
- Thorough review of Category 2 and Category 3 drugs:
° Precedents
° Analysis
- Review and comment on PMPRB announcements published over the last few years.
Why should you attend?
To develop a greater understanding of PMPRB rules and policies.
Learn these things from the experts!
Brogan Inc. has been consulting with the pharmaceutical industry on Patented Medicine Prices Review Board [PMPRB] issues since 1989. Our vast experience, backed by detailed knowledge of the Patent Act and the Board's Guidelines, includes:
- New drug submissions
- Data filing
- Compliance strategies
Who should attend?
This seminar is useful to anyone involved in patented medicines strategic pricing issues, including:
- Anyone involved in high-level pricing decisions
- Anyone involved in resolving PMPRB conflicts
- Executives [Presidents, Vice-Presidents, Directors]
For more information, please contact our office at 613.599.0711 extension 255.
|
